Skip to main content
Veterinary Medicines

Thiamacare 10 mg/ml Oral Solutions for Cats

Authorised
  • Thiamazole

Product identification

Medicine name:
Thiamacare 10 mg/mL soluzione orale per gatti
Thiamacare 10 mg/ml Oral Solutions for Cats
Active substance:
  • Thiamazole
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Thiamazole
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03BB02
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Cardboard box with 1 bottle of 30 ml and an oral syringe of 1.0 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105647
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0343/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 22/03/2023

Summary of Product Characteristics

English (PDF)
Published on: 21/12/2023
Download

Package Leaflet

English (PDF)
Published on: 21/12/2023
Download

eu-PUAR-esv0343001-dcp-thiamacare-10-mg-ml-oral-solutions-for-cats-en.pdf

English (PDF)
Published on: 21/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."